Workflow
Antibody Targeted Therapy Conjugates Platform
icon
Search documents
HUTCHMED (China) Limited (HCM) Discusses Antibody Targeted Therapy Conjugates Platform and Lead Candidate HMPL-A251 in R&D Update Transcript
Seeking Alphaยท 2025-10-31 23:36
Core Points - HUTCHMED is hosting its 2025 R&D Day event to discuss its research and development strategies and performance [1] Group 1 - The presentation is led by David Ng, the Head of Investor Relations & Capital Strategies, indicating a focus on investor engagement [1] - Dr. Michael Shi, the CMO and Head of R&D, is introduced to present the details of the event, highlighting the importance of R&D in the company's future [1]